Biotech Snap

Biotech Snap

A daily 5-min biotech briefing

Latest news

Daily Snap - 12. November 2025

Daily Snap - 12. November 2025

Joachim Eeckhout
Neurocrine’s depression drug fails trial, but investors shrug

Neurocrine’s depression drug fails trial, but investors shrug

Eduardo Longoria
Merck’s cholesterol pill could challenge injectables

Merck’s cholesterol pill could challenge injectables

Eduardo Longoria
Daily Snap - 11. November 2025

Daily Snap - 11. November 2025

Joachim Eeckhout
Lyell runs toward a promising CAR-T for colorectal cancer

Lyell runs toward a promising CAR-T for colorectal cancer

Eduardo Longoria
Lilly strikes eye-opening gene therapy deal for rare childhood blindness

Lilly strikes eye-opening gene therapy deal for rare childhood blindness

Eduardo Longoria
Daily Snap - 10. November 2025

Daily Snap - 10. November 2025

Joachim Eeckhout
PD-(L)1xVEGF bispecifics get their first survival win — Courtesy of Akeso

PD-(L)1xVEGF bispecifics get their first survival win — Courtesy of Akeso

Eduardo Longoria
AstraZeneca buys back its own startup for a new take on weight loss

AstraZeneca buys back its own startup for a new take on weight loss

Eduardo Longoria
Daily Snap - 7. November 2025

Daily Snap - 7. November 2025

Joachim Eeckhout
Axsome acquires AstraZeneca ́s epilepsy drug and runs with it

Axsome acquires AstraZeneca ́s epilepsy drug and runs with it

Joachim Eeckhout
Evommune soars past IPO slowdown with $150M debut amid federal shutdown

Evommune soars past IPO slowdown with $150M debut amid federal shutdown

Joachim Eeckhout
FirstBack
12345678
Next Last